| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06408-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-26065-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-24242 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-18527-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-18525-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-18526-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-18528-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-18524-0.025mg | |||
![Western Blot: MERS-CoV Spike Protein Antibody [NBP3-06408] - NBP3-06408 at 1:1000 dilution. Sample:MERS-CoV (NCoV / Novel coronavirus) (NCoV / Novel coronavirus) Spike protein (ECD, aa 1-1297) Lane A: 5ng Lane B: 2ng Lane C: 1ng Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-06408_rabbit-polyclonal-mers-cov-spike-protein-antibody-235202511354112.png "Western Blot: MERS-CoV Spike Protein Antibody [NBP3-06408] - NBP3-06408 at 1:1000 dilution. Sample:MERS-CoV (NCoV / Novel coronavirus) (NCoV / Novel coronavirus) Spike protein (ECD, aa 1-1297) Lane A: 5ng Lane B: 2ng Lane C: 1ng Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.")
![Western Blot: MERS-CoV Spike Protein Antibody (12) - Azide and BSA Free [NBP3-26065] - NBP3-26065 at 1:5000 dilution. Lane A: MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297) 40ng. Lane B: MERS-CoV Spike/S1 Protein (S1 Subunit, aa 1-725) 40ng Lane C: MERS-CoV Spike/S2 Protein (S2 Subunit, aa 726-1296) 40ng Lane D: MERS-CoV Spike/RBD Protein fragment (RBD, aa 367-606) 40ng Secondary Goat Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-26065_mouse-mers-cov-spike-protein-mab-12-azide-and-bsa-free-136202422345028.png "Western Blot: MERS-CoV Spike Protein Antibody (12) - Azide and BSA Free [NBP3-26065] - NBP3-26065 at 1:5000 dilution. Lane A: MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297) 40ng. Lane B: MERS-CoV Spike/S1 Protein (S1 Subunit, aa 1-725) 40ng Lane C: MERS-CoV Spike/S2 Protein (S2 Subunit, aa 726-1296) 40ng Lane D: MERS-CoV Spike/RBD Protein fragment (RBD, aa 367-606) 40ng Secondary Goat Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.")
![Immunohistochemistry-Paraffin: HBsAg Antibody (5C3) [NBP3-07121] - Formalin fixed paraffin embedded human infected liver stained with HBsAg antibody(NBP3-07121)](http://images.novusbio.com/fullsize/HBsAg-Antibody-5C3-Immunohistochemistry-Paraffin-NBP3-07121-img0001.jpg "Immunohistochemistry-Paraffin: HBsAg Antibody (5C3) [NBP3-07121] - Formalin fixed paraffin embedded human infected liver stained with HBsAg antibody(NBP3-07121)")
![ELISA: SARS-CoV-2 Spike Antibody (T3P3F4) - VHH - Azide and BSA Free [NBP3-18527] - ELISA Validation with Trimers of SARS1 and SARS-CoV-2 Variants. Antibodies: SARS-CoV-2 Spike Antibody, NBP3-18527. A direct ELISA was performed using spike trimer proteins of both SARS1 and SARS-CoV-2 Variants (Delta, Omicron BA.1 and BA.5) as coating antigens at 1 ug/mL and NBP3-18527 antibody at 20-2000 ng/mL, followed by anti-cMyc-tag antibody at 1 ug/mL. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5000 dilution. NBP3-18527 binds to all the spike trimers tested.](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-Antibody-T3P3F4-VHH-Azide-and-BSA-Free-ELISA-NBP3-18527-img0001.jpg "ELISA: SARS-CoV-2 Spike Antibody (T3P3F4) - VHH - Azide and BSA Free [NBP3-18527] - ELISA Validation with Trimers of SARS1 and SARS-CoV-2 Variants. Antibodies: SARS-CoV-2 Spike Antibody, NBP3-18527. A direct ELISA was performed using spike trimer proteins of both SARS1 and SARS-CoV-2 Variants (Delta, Omicron BA.1 and BA.5) as coating antigens at 1 ug/mL and NBP3-18527 antibody at 20-2000 ng/mL, followed by anti-cMyc-tag antibody at 1 ug/mL. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5000 dilution. NBP3-18527 binds to all the spike trimers tested.")
![ELISA: SARS-CoV-2 Spike Antibody (T3P1D2) - VHH - Azide and BSA Free [NBP3-18525] - ELISA Validation with Trimers of SARS1 and SARS-CoV-2 Variants. Antibodies: SARS-CoV-2 Spike Antibody, NBP3-18525. A direct ELISA was performed using spike trimer proteins of both SARS1 and SARS-CoV-2 Variants (Delta, Omicron BA.1 and BA.5) as coating antigens at 1 ug/mL and NBP3-18525 antibody at 20-2000 ng/mL, followed by anti-cMyc-tag antibody at 1 ug/mL. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5000 dilution. NBP3-18525 binds to all the spike trimers tested.](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-Antibody-T3P1D2-VHH-Azide-and-BSA-Free-ELISA-NBP3-18525-img0001.jpg "ELISA: SARS-CoV-2 Spike Antibody (T3P1D2) - VHH - Azide and BSA Free [NBP3-18525] - ELISA Validation with Trimers of SARS1 and SARS-CoV-2 Variants. Antibodies: SARS-CoV-2 Spike Antibody, NBP3-18525. A direct ELISA was performed using spike trimer proteins of both SARS1 and SARS-CoV-2 Variants (Delta, Omicron BA.1 and BA.5) as coating antigens at 1 ug/mL and NBP3-18525 antibody at 20-2000 ng/mL, followed by anti-cMyc-tag antibody at 1 ug/mL. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5000 dilution. NBP3-18525 binds to all the spike trimers tested.")
![ELISA: SARS-CoV-2 Spike Antibody (T3P2E1) - VHH - Azide and BSA Free [NBP3-18526] - ELISA Validation with Trimers of SARS1 and SARS-CoV-2 Variants. Antibodies: SARS-CoV-2 Spike Antibody, NBP3-18526. A direct ELISA was performed using spike trimer proteins of both SARS1 and SARS-CoV-2 Variants (Delta, Omicron BA.1 and BA.5) as coating antigens at 1 ug/mL and NBP3-18526 antibody at 20-2000 ng/mL, followed by anti-cMyc-tag antibody at 1 ug/mL. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5000 dilution. NBP3-18526 binds to all the spike trimers tested.](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-Antibody-T3P2E1-VHH-Azide-and-BSA-Free-ELISA-NBP3-18526-img0001.jpg "ELISA: SARS-CoV-2 Spike Antibody (T3P2E1) - VHH - Azide and BSA Free [NBP3-18526] - ELISA Validation with Trimers of SARS1 and SARS-CoV-2 Variants. Antibodies: SARS-CoV-2 Spike Antibody, NBP3-18526. A direct ELISA was performed using spike trimer proteins of both SARS1 and SARS-CoV-2 Variants (Delta, Omicron BA.1 and BA.5) as coating antigens at 1 ug/mL and NBP3-18526 antibody at 20-2000 ng/mL, followed by anti-cMyc-tag antibody at 1 ug/mL. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5000 dilution. NBP3-18526 binds to all the spike trimers tested.")
![ELISA: SARS-CoV-2 Spike Antibody (T3P1C4) - VHH - Azide and BSA Free [NBP3-18528] - ELISA Validation with Trimers of SARS1 and SARS-CoV-2 Variants. Antibodies: SARS-CoV-2 Spike Antibody, NBP3-18528. A direct ELISA was performed using spike trimer proteins of both SARS1 and SARS-CoV-2 Variants (Delta, Omicron BA.1 and BA.5) as coating antigens at 1 ug/mL and NBP3-18528 antibody at 20-2000 ng/mL, followed by anti-cMyc-tag antibody at 1 ug/mL. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5000 dilution. NBP3-18528 binds to all the spike trimers tested.](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-Antibody-T3P1C4-VHH-Azide-and-BSA-Free-ELISA-NBP3-18528-img0001.jpg "ELISA: SARS-CoV-2 Spike Antibody (T3P1C4) - VHH - Azide and BSA Free [NBP3-18528] - ELISA Validation with Trimers of SARS1 and SARS-CoV-2 Variants. Antibodies: SARS-CoV-2 Spike Antibody, NBP3-18528. A direct ELISA was performed using spike trimer proteins of both SARS1 and SARS-CoV-2 Variants (Delta, Omicron BA.1 and BA.5) as coating antigens at 1 ug/mL and NBP3-18528 antibody at 20-2000 ng/mL, followed by anti-cMyc-tag antibody at 1 ug/mL. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5000 dilution. NBP3-18528 binds to all the spike trimers tested.")
![ELISA: SARS-CoV-2 Spike Antibody (T3P2D11) - VHH - Azide and BSA Free [NBP3-18524] - ELISA Validation with Trimers of SARS1 and SARS-CoV-2 Variants. Antibodies: SARS-CoV-2 Spike Antibody, NBP3-18524. A direct ELISA was performed using spike trimer proteins of both SARS1 and SARS-CoV-2 Variants (Delta, Omicron BA.1 and BA.5) as coating antigens at 1 ug/mL and NBP3-18524 antibody at 20-2000 ng/mL, followed by anti-cMyc-tag antibody at 1 ug/mL. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5000 dilution. NBP3-18524 binds to all the spike trimers tested.](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-Antibody-T3P2D11-VHH-Azide-and-BSA-Free-ELISA-NBP3-18524-img0001.jpg "ELISA: SARS-CoV-2 Spike Antibody (T3P2D11) - VHH - Azide and BSA Free [NBP3-18524] - ELISA Validation with Trimers of SARS1 and SARS-CoV-2 Variants. Antibodies: SARS-CoV-2 Spike Antibody, NBP3-18524. A direct ELISA was performed using spike trimer proteins of both SARS1 and SARS-CoV-2 Variants (Delta, Omicron BA.1 and BA.5) as coating antigens at 1 ug/mL and NBP3-18524 antibody at 20-2000 ng/mL, followed by anti-cMyc-tag antibody at 1 ug/mL. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5000 dilution. NBP3-18524 binds to all the spike trimers tested.")